{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:17:15Z","timestamp":1791980235239,"version":"4.4.0"},"reference-count":118,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Once an obscure disease, recent studies have transformed our understanding of angioimmunoblastic T-cell lymphoma (AITL). In this review, we summarize new major advances in the genetics and biology of AITL.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Genome wide sequencing studies have dissected the repertoire of the genetic alterations driving AITL uncovering a highly recurrent Gly17Val somatic mutation in the small GTPase RHOA and major role for mutations in epigenetic regulators, such as <jats:italic toggle=\"yes\">TET2<\/jats:italic>, <jats:italic toggle=\"yes\">DNMT3A<\/jats:italic> and <jats:italic toggle=\"yes\">IDH2<\/jats:italic>, and signaling factors (e.g., FYN and CD28). These findings support a multistep model of follicular T helper cell transformation in AITL and pinpoint novel candidates for the development of targeted therapies in this disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>AITL originates from follicular T helper cells and is characterized by the presence of RHOA G17V mutation together with genetic alterations in TET2, DNMT3A, and IDH2. Research efforts now focus on the elucidation of the specific roles and interplay of these genetic alterations in the pathogenesis of AITL.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/moh.0000000000000261","type":"journal-article","created":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T11:40:04Z","timestamp":1463053204000},"page":"434-443","source":"Crossref","is-referenced-by-count":55,"title":["The curious origins of angioimmunoblastic T-cell lymphoma"],"prefix":"10.1097","volume":"23","author":[{"given":"Jos\u00e9 R.","family":"Cort\u00e9s","sequence":"first","affiliation":[{"name":"Institute for Cancer Genetics, Columbia University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Palomero","sequence":"additional","affiliation":[{"name":"Institute for Cancer Genetics, Columbia University"},{"name":"Department of Pathology and Cell Biology, Columbia University Medical Center, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230917","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2141.2009.08003.x","article-title":"Advances in the understanding and management of angioimmunoblastic T-cell lymphoma","volume":"148","author":"de Leval","year":"2010","journal-title":"Br J Haematol"},{"key":"R2-20230917","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","article-title":"Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project","volume":"31","author":"Federico","year":"2013","journal-title":"J Clin Oncol"},{"key":"R3-20230917","doi-asserted-by":"crossref","first-page":"e92585","DOI":"10.1371\/journal.pone.0092585","article-title":"No survival improvement for patients with angioimmunoblastic T-cell lymphoma over the past two decades: a population-based study of 1207 cases","volume":"9","author":"Xu","year":"2014","journal-title":"PLoS One"},{"key":"R4-20230917","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/sj.leu.2403960","article-title":"Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas","volume":"19","author":"Martinez-Delgado","year":"2005","journal-title":"Leukemia"},{"key":"R5-20230917","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/sj.onc.1209178","article-title":"Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas","volume":"25","author":"Ballester","year":"2006","journal-title":"Oncogene"},{"key":"R6-20230917","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/hon.781","article-title":"Peripheral T-cell lymphoma gene expression profiles","volume":"24","author":"Martinez-Delgado","year":"2006","journal-title":"Hematol Oncol"},{"key":"R7-20230917","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","article-title":"The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells","volume":"109","author":"de Leval","year":"2007","journal-title":"Blood"},{"key":"R8-20230917","doi-asserted-by":"crossref","first-page":"10703","DOI":"10.1158\/0008-5472.CAN-07-1708","article-title":"Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation","volume":"67","author":"Piccaluga","year":"2007","journal-title":"Cancer Res"},{"key":"R9-20230917","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1172\/JCI26833","article-title":"Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets","volume":"117","author":"Piccaluga","year":"2007","journal-title":"J Clin Invest"},{"key":"R10-20230917","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1200\/JCO.2006.09.4474","article-title":"Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas","volume":"25","author":"Cuadros","year":"2007","journal-title":"J Clin Oncol"},{"key":"R11-20230917","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1182\/blood-2009-06-227579","article-title":"Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma","volume":"115","author":"Iqbal","year":"2010","journal-title":"Blood"},{"key":"R12-20230917","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","article-title":"Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma","volume":"123","author":"Iqbal","year":"2014","journal-title":"Blood"},{"key":"R13-20230917","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.blre.2015.08.003","article-title":"Genomic signatures in T-cell lymphoma: how can these improve precision in diagnosis and inform prognosis?","volume":"30","author":"Iqbal","year":"2016","journal-title":"Blood Rev"},{"key":"R14-20230917","article-title":"Molecular genetics of peripheral T-cell lymphomas","author":"Piccaluga","year":"2015","journal-title":"eLS [Internet]"},{"key":"R15-20230917","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.semcancer.2013.11.004","article-title":"The microenvironment in T-cell lymphomas: emerging themes","volume":"24","author":"Gaulard","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"R16-20230917","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12185-014-1522-1","article-title":"Molecular genetics of peripheral T-cell lymphomas","volume":"99","author":"Piccaluga","year":"2014","journal-title":"Int J Hematol"},{"key":"R17-20230917","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00000478-200604000-00009","article-title":"Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells","volume":"30","author":"Dupuis","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R18-20230917","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/modpathol.3800625","article-title":"Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified","volume":"19","author":"Grogg","year":"2006","journal-title":"Mod Pathol"},{"key":"R19-20230917","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1084\/jem.192.11.1553","article-title":"CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function","volume":"192","author":"Schaerli","year":"2000","journal-title":"J Exp Med"},{"key":"R20-20230917","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1084\/jem.193.12.1373","article-title":"Subspecialization of CXCR5+ T cells: B helper activity is focused in a germinal center-localized subset of CXCR5+ T cells","volume":"193","author":"Kim","year":"2001","journal-title":"J Exp Med"},{"key":"R21-20230917","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1084\/jem.192.11.1545","article-title":"Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production","volume":"192","author":"Breitfeld","year":"2000","journal-title":"J Exp Med"},{"key":"R22-20230917","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4049\/jimmunol.173.1.68","article-title":"T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1\/Th2 effector cells that provide help for B cells","volume":"173","author":"Chtanova","year":"2004","journal-title":"J Immunol"},{"key":"R23-20230917","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/ni.3054","article-title":"Pathophysiology of T follicular helper cells in humans and mice","volume":"16","author":"Ueno","year":"2015","journal-title":"Nat Immunol"},{"key":"R24-20230917","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nature03555","article-title":"A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity","volume":"435","author":"Vinuesa","year":"2005","journal-title":"Nature"},{"key":"R25-20230917","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-immunol-041015-055605","article-title":"Follicular helper T cells","author":"Vinuesa","year":"2016","journal-title":"Annu Rev Immunol"},{"key":"R26-20230917","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.4049\/jimmunol.1100853","article-title":"Cutting edge: dendritic cell-restricted antigen presentation initiates the follicular helper T cell program but cannot complete ultimate effector differentiation","volume":"187","author":"Goenka","year":"2011","journal-title":"J Immunol"},{"key":"R27-20230917","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.immuni.2015.01.017","article-title":"ICOS coreceptor signaling inactivates the transcription factor FOXO1 to promote Tfh cell differentiation","volume":"42","author":"Stone","year":"2015","journal-title":"Immunity"},{"key":"R28-20230917","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1084\/jem.20141432","article-title":"ICOS maintains the T follicular helper cell phenotype by down-regulating Kruppel-like factor 2","volume":"212","author":"Weber","year":"2015","journal-title":"J Exp Med"},{"key":"R29-20230917","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/ni.3050","article-title":"A p85alpha-osteopontin axis couples the receptor ICOS to sustained Bcl-6 expression by follicular helper and regulatory T cells","volume":"16","author":"Leavenworth","year":"2015","journal-title":"Nat Immunol"},{"key":"R30-20230917","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","article-title":"T follicular helper cell differentiation, function, and roles in disease","volume":"41","author":"Crotty","year":"2014","journal-title":"Immunity"},{"key":"R31-20230917","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/imr.12040","article-title":"Transcriptional regulation of follicular T-helper (Tfh) cells","volume":"252","author":"Liu","year":"2013","journal-title":"Immunol Rev"},{"key":"R32-20230917","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1126\/science.1176676","article-title":"Bcl6 mediates the development of T follicular helper cells","volume":"325","author":"Nurieva","year":"2009","journal-title":"Science"},{"key":"R33-20230917","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.coi.2009.09.013","article-title":"Lineage specification and heterogeneity of T follicular helper cells","volume":"21","author":"Yu","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"R34-20230917","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1126\/science.1175870","article-title":"Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation","volume":"325","author":"Johnston","year":"2009","journal-title":"Science"},{"key":"R35-20230917","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1084\/jem.20141380","article-title":"BCL6 orchestrates Tfh cell differentiation via multiple distinct mechanisms","volume":"212","author":"Hatzi","year":"2015","journal-title":"J Exp Med"},{"key":"R36-20230917","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/978-94-017-9487-9_6","article-title":"Tfh cell differentiation and their function in promoting B-cell responses","volume":"841","author":"Qi","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"R37-20230917","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.immuni.2011.03.023","article-title":"ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6","volume":"34","author":"Choi","year":"2011","journal-title":"Immunity"},{"key":"R38-20230917","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nature12910","article-title":"Transcription factor achaete-scute homologue 2 initiates follicular T-helper-cell development","volume":"507","author":"Liu","year":"2014","journal-title":"Nature"},{"key":"R39-20230917","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.4049\/jimmunol.1103246","article-title":"Bcl6 and Maf cooperate to instruct human follicular helper CD4 T cell differentiation","volume":"188","author":"Kroenke","year":"2012","journal-title":"J Immunol"},{"key":"R40-20230917","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.immuni.2009.10.008","article-title":"Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors","volume":"31","author":"Kwon","year":"2009","journal-title":"Immunity"},{"key":"R41-20230917","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.immuni.2008.05.009","article-title":"Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages","volume":"29","author":"Nurieva","year":"2008","journal-title":"Immunity"},{"key":"R42-20230917","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/ni.2030","article-title":"Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages","volume":"12","author":"Liao","year":"2011","journal-title":"Nat Immunol"},{"key":"R43-20230917","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.4049\/jimmunol.1202963","article-title":"Bcl6 expressing follicular helper CD4 T cells are fate committed early and have the capacity to form memory","volume":"190","author":"Choi","year":"2013","journal-title":"J Immunol"},{"key":"R44-20230917","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1084\/jem.20072057","article-title":"Development and characterization of IL-21-producing CD4+ T cells","volume":"205","author":"Suto","year":"2008","journal-title":"J Exp Med"},{"key":"R45-20230917","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/icb.2009.64","article-title":"Early commitment of naive human CD4(+) T cells to the T follicular helper (T(FH)) cell lineage is induced by IL-12","volume":"87","author":"Ma","year":"2009","journal-title":"Immunol Cell Biol"},{"key":"R46-20230917","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1182\/blood-2012-08-448902","article-title":"IL-12 receptor beta1 deficiency alters in vivo T follicular helper cell response in humans","volume":"121","author":"Schmitt","year":"2013","journal-title":"Blood"},{"key":"R47-20230917","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.immuni.2009.04.016","article-title":"Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12","volume":"31","author":"Schmitt","year":"2009","journal-title":"Immunity"},{"key":"R48-20230917","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.cellbio.21.020604.150721","article-title":"Rho GTPases: biochemistry and biology","volume":"21","author":"Jaffe","year":"2005","journal-title":"Annu Rev Cell Dev Biol"},{"key":"R49-20230917","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1096\/fj.11-192252","article-title":"Off the beaten paths: alternative and crosstalk regulation of Rho GTPases","volume":"26","author":"Boulter","year":"2012","journal-title":"FASEB J"},{"key":"R50-20230917","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1002\/(SICI)1521-4141(199911)29:11<3609::AID-IMMU3609>3.0.CO;2-S","article-title":"Rho GTPases control migration and polarization of adhesion molecules and cytoskeletal ERM components in T lymphocytes","volume":"29","author":"del Pozo","year":"1999","journal-title":"Eur J Immunol"},{"key":"R51-20230917","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1083\/jcb.201002067","article-title":"Coordinated RhoA signaling at the leading edge and uropod is required for T cell transendothelial migration","volume":"190","author":"Heasman","year":"2010","journal-title":"J Cell Biol"},{"key":"R52-20230917","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4161\/sgtp.1.3.14724","article-title":"Multiple roles for RhoA during T cell transendothelial migration","volume":"1","author":"Heasman","year":"2010","journal-title":"Small GTPases"},{"key":"R53-20230917","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1084\/jem.20111692","article-title":"The Mst1 and Mst2 kinases control activation of rho family GTPases and thymic egress of mature thymocytes","volume":"209","author":"Mou","year":"2012","journal-title":"J Exp Med"},{"key":"R54-20230917","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1084\/jem.194.7.903","article-title":"Analysis of thymocyte development reveals that the GTPase RhoA is a positive regulator of T cell receptor responses in vivo","volume":"194","author":"Corre","year":"2001","journal-title":"J Exp Med"},{"key":"R55-20230917","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1093\/emboj\/16.9.2397","article-title":"The GTPase Rho has a critical regulatory role in thymus development","volume":"16","author":"Henning","year":"1997","journal-title":"EMBO J"},{"key":"R56-20230917","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1074-7613(00)80519-1","article-title":"Different functions of the GTPase Rho in prothymocytes and late pre-T cells","volume":"7","author":"Galandrini","year":"1997","journal-title":"Immunity"},{"key":"R57-20230917","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0960-9822(99)80289-9","article-title":"Inhibition of Rho at different stages of thymocyte development gives different perspectives on Rho function","volume":"9","author":"Cleverley","year":"1999","journal-title":"Curr Biol"},{"key":"R58-20230917","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.onc.1203259","article-title":"Loss of Rho function in the thymus is accompanied by the development of thymic lymphoma","volume":"19","author":"Cleverley","year":"2000","journal-title":"Oncogene"},{"key":"R59-20230917","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.4049\/jimmunol.1400839","article-title":"Gene targeting RhoA reveals its essential role in coordinating mitochondrial function and thymocyte development","volume":"193","author":"Zhang","year":"2014","journal-title":"J Immunol"},{"key":"R60-20230917","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.autrev.2008.07.044","article-title":"Rho GTPase-mediated pathways in mature CD4+ T cells","volume":"8","author":"Pernis","year":"2009","journal-title":"Autoimmun Rev"},{"key":"R61-20230917","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas","volume":"46","author":"Palomero","year":"2014","journal-title":"Nat Genet"},{"key":"R62-20230917","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nat Genet"},{"key":"R63-20230917","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ng.2916","article-title":"A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma","volume":"46","author":"Yoo","year":"2014","journal-title":"Nat Genet"},{"key":"R64-20230917","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood-2015-05-644591","article-title":"IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma","volume":"126","author":"Wang","year":"2015","journal-title":"Blood"},{"key":"R65-20230917","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1182\/blood-2014-02-555946","article-title":"The RHOA G17V gene mutation occurs frequently in peripheral T-cell lymphoma and is associated with a characteristic molecular signature","volume":"123","author":"Manso","year":"2014","journal-title":"Blood"},{"key":"R66-20230917","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/PAS.0000000000000555","article-title":"Angioimmunoblastic T-cell lymphomas with the RHOA p.Gly17Val mutation have classic clinical and pathologic features","volume":"40","author":"Ondrejka","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R67-20230917","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/gcc.22202","article-title":"Recurrent RHOA mutations in pediatric Burkitt lymphoma treated according to the NHL-BFM protocols","volume":"53","author":"Rohde","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"R68-20230917","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/ng.2984","article-title":"Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma","volume":"46","author":"Kakiuchi","year":"2014","journal-title":"Nat Genet"},{"key":"R69-20230917","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/ng.2983","article-title":"Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer","volume":"46","author":"Wang","year":"2014","journal-title":"Nat Genet"},{"key":"R70-20230917","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1182\/blood-2015-06-644948","article-title":"Variegated RHOA mutations in adult T-cell leukemia\/lymphoma","volume":"127","author":"Nagata","year":"2016","journal-title":"Blood"},{"key":"R71-20230917","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","article-title":"TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis","volume":"20","author":"Quivoron","year":"2011","journal-title":"Cancer Cell"},{"key":"R72-20230917","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJMc1111708","article-title":"TET2 and DNMT3A mutations in human T-cell lymphoma","volume":"366","author":"Couronne","year":"2012","journal-title":"N Engl J Med"},{"key":"R73-20230917","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2011-11-391748","article-title":"IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma","volume":"119","author":"Cairns","year":"2012","journal-title":"Blood"},{"key":"R74-20230917","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1126\/science.1170116","article-title":"Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1","volume":"324","author":"Tahiliani","year":"2009","journal-title":"Science"},{"key":"R75-20230917","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/nature09303","article-title":"Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification","volume":"466","author":"Ito","year":"2010","journal-title":"Nature"},{"key":"R76-20230917","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.stem.2011.08.007","article-title":"TET family proteins and their role in stem cell differentiation and transformation","volume":"9","author":"Cimmino","year":"2011","journal-title":"Cell Stem Cell"},{"key":"R77-20230917","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11899-011-0108-8","article-title":"Role of TET2 mutations in myeloproliferative neoplasms","volume":"7","author":"Pronier","year":"2012","journal-title":"Curr Hematol Malig Rep"},{"key":"R78-20230917","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1182\/blood-2009-03-210039","article-title":"Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies","volume":"114","author":"Abdel-Wahab","year":"2009","journal-title":"Blood"},{"issue":"(Suppl 4)","key":"R79-20230917","doi-asserted-by":"crossref","first-page":"iv74","DOI":"10.1093\/annonc\/mdn203","article-title":"Update on T-cell lymphoma","volume":"19","author":"Vose","year":"2008","journal-title":"Ann Oncol"},{"key":"R80-20230917","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","article-title":"Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters","volume":"120","author":"Lemonnier","year":"2012","journal-title":"Blood"},{"key":"R81-20230917","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2011.06.001","article-title":"Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation","volume":"20","author":"Moran-Crusio","year":"2011","journal-title":"Cancer Cell"},{"key":"R82-20230917","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1182\/blood-2010-12-325241","article-title":"Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies","volume":"118","author":"Li","year":"2011","journal-title":"Blood"},{"key":"R83-20230917","doi-asserted-by":"crossref","first-page":"14566","DOI":"10.1073\/pnas.1112317108","article-title":"Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice","volume":"108","author":"Ko","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R84-20230917","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1182\/blood-2011-08-373357","article-title":"TET2: epigenetic safeguard for HSC","volume":"118","author":"Ko","year":"2011","journal-title":"Blood"},{"key":"R85-20230917","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.stem.2011.01.008","article-title":"Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells","volume":"8","author":"Koh","year":"2011","journal-title":"Cell Stem Cell"},{"key":"R86-20230917","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/srep00273","article-title":"Tet2 disruption leads to enhanced self-renewal and altered differentiation of fetal liver hematopoietic stem cells","volume":"2","author":"Kunimoto","year":"2012","journal-title":"Sci Rep"},{"key":"R87-20230917","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1038\/leu.2012.94","article-title":"TET2 is essential for survival and hematopoietic stem cell homeostasis","volume":"26","author":"Shide","year":"2012","journal-title":"Leukemia"},{"key":"R88-20230917","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.1038\/bcj.2014.83","article-title":"Reduced TET2 function leads to T-cell lymphoma with follicular helper T-cell-like features in mice","volume":"4","author":"Muto","year":"2014","journal-title":"Blood Cancer J"},{"key":"R89-20230917","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1056\/NEJMoa1005143","article-title":"DNMT3A mutations in acute myeloid leukemia","volume":"363","author":"Ley","year":"2010","journal-title":"N Engl J Med"},{"key":"R90-20230917","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ng0411-289","article-title":"DNMT3A mutations in acute myeloid leukemia","volume":"43","author":"Shah","year":"2011","journal-title":"Nat Genet"},{"key":"R91-20230917","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1182\/blood-2012-04-423905","article-title":"Mutant DNMT3A: teaming up to transform","volume":"119","author":"Thiede","year":"2012","journal-title":"Blood"},{"key":"R92-20230917","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pharmthera.2015.05.003","article-title":"Metabolic consequences of oncogenic IDH mutations","volume":"152","author":"Parker","year":"2015","journal-title":"Pharmacol Ther"},{"key":"R93-20230917","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.molmed.2010.07.002","article-title":"IDH mutations in glioma and acute myeloid leukemia","volume":"16","author":"Dang","year":"2010","journal-title":"Trends Mol Med"},{"key":"R94-20230917","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1101\/gad.226753.113","article-title":"Induction of sarcomas by mutant IDH2","volume":"27","author":"Lu","year":"2013","journal-title":"Genes Dev"},{"key":"R95-20230917","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1074\/jbc.M112.435495","article-title":"The potential for isocitrate dehydrogenase mutations to produce 2-hydroxyglutarate depends on allele specificity and subcellular compartmentalization","volume":"288","author":"Ward","year":"2013","journal-title":"J Biol Chem"},{"key":"R96-20230917","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1200\/JCO.2010.28.3762","article-title":"IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication","volume":"28","author":"Paschka","year":"2010","journal-title":"J Clin Oncol"},{"key":"R97-20230917","article-title":"Recurrent activating mutations of CD28 in peripheral T-cell lymphomas","author":"Rohr","year":"2015","journal-title":"Leukemia"},{"key":"R98-20230917","doi-asserted-by":"crossref","first-page":"7990","DOI":"10.1038\/sj.onc.1208074","article-title":"Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation","volume":"23","author":"Palacios","year":"2004","journal-title":"Oncogene"},{"key":"R99-20230917","doi-asserted-by":"crossref","first-page":"e505","DOI":"10.3324\/haematol.2015.133074","article-title":"A highly recurrent novel missense mutation in CD28 among angioimmunoblastic T-cell lymphoma patients","volume":"100","author":"Lee","year":"2015","journal-title":"Haematologica"},{"key":"R100-20230917","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies","volume":"20","author":"Xie","year":"2014","journal-title":"Nat Med"},{"key":"R101-20230917","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"key":"R102-20230917","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"key":"R103-20230917","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.4049\/jimmunol.1300378","article-title":"Insights into the role of Bcl6 in follicular Th cells using a new conditional mutant mouse model","volume":"191","author":"Hollister","year":"2013","journal-title":"J Immunol"},{"key":"R104-20230917","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/ni.2543","article-title":"Lineage-specific functions of Bcl-6 in immunity and inflammation are mediated by distinct biochemical mechanisms","volume":"14","author":"Huang","year":"2013","journal-title":"Nat Immunol"},{"key":"R105-20230917","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1586\/17474086.2013.826928","article-title":"Targeting BCL6 in diffuse large B-cell lymphoma: what does this mean for the future treatment?","volume":"6","author":"Cerchietti","year":"2013","journal-title":"Expert Rev Hematol"},{"key":"R106-20230917","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.18632\/oncotarget.6513","article-title":"Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma","volume":"7","author":"Dupont","year":"2016","journal-title":"Oncotarget"},{"key":"R107-20230917","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.4049\/jimmunol.1001311","article-title":"Abatacept limits breach of self-tolerance in a murine model of arthritis via effects on the generation of T follicular helper cells","volume":"185","author":"Platt","year":"2010","journal-title":"J Immunol"},{"key":"R108-20230917","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/bjh.12941","article-title":"Follicular helper T-cells: expanding roles in T-cell lymphoma and targets for treatment","volume":"166","author":"Ahearne","year":"2014","journal-title":"Br J Haematol"},{"key":"R109-20230917","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1158\/1078-0432.CCR-14-2034","article-title":"Idelalisib: first-in-class PI3K delta inhibitor for the treatment of chronic lymphocytic leukemia, small lymphocytic leukemia, and follicular lymphoma","volume":"21","author":"Yang","year":"2015","journal-title":"Clin Cancer Res"},{"key":"R110-20230917","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.4049\/jimmunol.1401190","article-title":"Cutting edge: circulating plasmablasts induce the differentiation of human T follicular helper cells via IL-6 production","volume":"194","author":"Chavele","year":"2015","journal-title":"J Immunol"},{"key":"R111-20230917","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1002\/art.39233","article-title":"Interleukin-21 receptor blockade inhibits secondary humoral responses and halts the progression of preestablished disease in the (NZB\u200a\u00d7\u200aNZW)F1 systemic lupus erythematosus model","volume":"67","author":"Zhang","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R112-20230917","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1038\/jid.2014.199","article-title":"Exploring the IL-21-STAT3 axis as therapeutic target for Sezary syndrome","volume":"134","author":"van der Fits","year":"2014","journal-title":"J Invest Dermatol"},{"key":"R113-20230917","doi-asserted-by":"crossref","first-page":"314ra185","DOI":"10.1126\/scitranslmed.aac5272","article-title":"AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer","volume":"7","author":"Hong","year":"2015","journal-title":"Sci Transl Med"},{"key":"R114-20230917","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12865-015-0068-1","article-title":"CXCL13 antibody for the treatment of autoimmune disorders","volume":"16","author":"Klimatcheva","year":"2015","journal-title":"BMC Immunol"},{"key":"R115-20230917","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1182\/blood-2014-06-582809","article-title":"TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients","volume":"124","author":"Bejar","year":"2014","journal-title":"Blood"},{"key":"R116-20230917","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/bjh.13170","article-title":"Efficacy of 5-azacytidine in a TET2 mutated angioimmunoblastic T cell lymphoma","volume":"168","author":"Cheminant","year":"2015","journal-title":"Br J Haematol"},{"key":"R117-20230917","first-page":"569","article-title":"AG-221, an oral, selective, first-in-class, potent inhibitor of the IDH2 mutant enzyme, induced durable responses in a phase 1 study of IDH2 mutation-positive advanced hematologic malignancies","author":"DiNardo","year":"2015","journal-title":"Haematol Eur Hematol Assoc Annu Meet"},{"key":"R118-20230917","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.beha.2015.10.016","article-title":"IDH2 inhibition in AML: finally progress?","volume":"28","author":"Stein","year":"2015","journal-title":"Best Pract Res Clin Haematol"}],"container-title":["Current Opinion in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00062752-201607000-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T06:05:51Z","timestamp":1694930751000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00062752-201607000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":118,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/moh.0000000000000261","relation":{},"ISSN":["1065-6251","1531-7048"],"issn-type":[{"value":"1065-6251","type":"print"},{"value":"1531-7048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}